← Back to Search

Text Messaging for Lumbar Spine Surgery Recovery (NOTICE Trial)

N/A
Recruiting
Led By Oren N Gottfried, MD FAANS
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Degenerative spine diagnosis
18 years or older
Must not have
Prior lumbar fusions
Non-English speaking patients
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 30 days
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare how effective informative text messages are to traditional handouts in helping patients recover from lumbar spine surgery.

Who is the study for?
This trial is for adults over 18 with degenerative spine conditions who are having lumbar fusion surgery. Participants must own and be comfortable using a mobile phone for daily texting. It's not for non-English speakers, smokers, those with uncontrolled diabetes, or anyone previously having lumbar fusions or certain other health issues.
What is being tested?
The study is testing if sending informative text messages to patients after their lumbar spine surgery helps better than traditional handouts. Patients will randomly receive either texts or handouts and the effectiveness of these methods will be compared.
What are the potential side effects?
Since this trial involves communication methods rather than medical treatments, there are no direct side effects related to medications or procedures. However, participants may experience varying levels of satisfaction or stress based on the method they receive.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with a degenerative spine condition.
Select...
I am 18 years old or older.
Select...
I had a spinal fusion surgery in my lower back involving 1 to 4 levels.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had surgery to join two or more spine bones in my lower back.
Select...
I do not speak English.
Select...
I smoke or have diabetes that is not well-controlled.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 30 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in readmission rates within 30 days post-lumbar spine surgery.
Secondary study objectives
Change in Emergency Department (ED) visit rates within 30 days post-lumbar spine surgery.
Change in anxiety/depression levels within 30 days post-lumbar spine surgery as measured by "European Quality of Life-5 Dimension" (EQ-5D) questionnaire.
Change in back and leg pain levels within 30 days post-lumbar spine surgery as measured by "Oswestry Disability Index" (ODI) questionnaire.
Other study objectives
Change in patient satisfaction levels within 30 days post-lumbar spine surgery.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ARM 1: Text Message GroupExperimental Treatment1 Intervention
The intervention group will receive automated text messages every day for the first week, and every other day for the second week post-operatively. The text messages will follow a series of pre-defined standardized scripts (Appendix 3) with embedded hyperlinks to a video from the providers with further advice. The patient is directed not to respond to the text messages, but to call for any questions or concerns. The text message group will receive a 30-day post-operative phone call to evaluate: number of ED visits, hospital readmissions, and to re-administer the questionnaires completed at baseline visit. Other data to be collected may include the following: number of phone calls to provider, MyChart messages to provider, pain medications, and new problems like pain and infection.
Group II: ARM 2: Control groupActive Control1 Intervention
The control group will be given the standard post-op packet that includes detailed instructions on proper wound care and signs and symptoms of infection. They will not receive text messages. The same outcomes will be assessed in both groups through a 30-day post-operative phone call.

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,455 Previous Clinical Trials
2,970,855 Total Patients Enrolled
Oren N Gottfried, MD FAANSPrincipal InvestigatorDuke Neurosurgery
Oren N Gottfried, MD FAANS FACSPrincipal InvestigatorDuke Neurosurgery

Media Library

Text Message Group Clinical Trial Eligibility Overview. Trial Name: NCT04140344 — N/A
Lumbar Spondylosis Research Study Groups: ARM 1: Text Message Group, ARM 2: Control group
Lumbar Spondylosis Clinical Trial 2023: Text Message Group Highlights & Side Effects. Trial Name: NCT04140344 — N/A
Text Message Group 2023 Treatment Timeline for Medical Study. Trial Name: NCT04140344 — N/A
~93 spots leftby Oct 2025